Change in weight (kg) · malnourished or nutritionally at‐risk adults
1 finding from 1 review
Costs · malnourished or nutritionally at‐risk adults
1 finding from 1 review
Costs (direct costs of interventions) · people at increased risk for developing type 2 diabetes
1 finding from 1 review
Intervention not reported
Adverse events 1. All adverse events 2. Drop‐outs due to adverse events Interventions vs thiazolidinediones [1. 6 months to 12 months] [2. 24 weeks to 52 weeks] · participants with type 2 diabetes mellitus
The intervention may leads to lower adverse events 1. All adverse events 2. Drop‐outs due to adverse… (low certainty).
1 finding from 1 review
RR 0.88 [0.78, 0.99]
1 study · 3 participants
Low
Intervention not reported
Health‐related quality of life [ · participants with type 2 diabetes mellitus Interventions
1 finding from 1 review
Intervention not reported
Death from any cause [ · participants with type 2 diabetes mellitus Interventions
1 finding from 1 review
Intervention not reported
Depression [ · participants with type 2 diabetes mellitus Interventions
1 finding from 1 review
Intervention not reported
Adverse effects [ · participants with type 2 diabetes mellitus Interventions
1 finding from 1 review
Intervention not reported
HbA1c [%] [ · participants with type 2 diabetes mellitus Interventions
1 finding from 1 review
Intervention not reported
Economic data [ · participants with type 2 diabetes mellitus Interventions
1 finding from 1 review
Weight regain (change in kg weight) · adults with overweight or obesity
1 finding from 1 review
Physical‐activity related outcomes · adults with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost‐effectiveness · adults with overweight or obesity
1 finding from 1 review
Health‐related quality of life · adults with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · adults with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Weight loss (change in kg weight) · adults with overweight or obesity
1 finding from 1 review
Disease‐related complications · adults with growth‐hormone secreting pituitary adenomas
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · adults with growth‐hormone secreting pituitary adenomas
It is very uncertain whether surgery alone changes adverse events compared with preoperative pharmacological therapy and surgery (very low certainty).
1 finding from 1 review
All‐cause mortality · adults with growth‐hormone secreting pituitary adenomas
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Surgery for recurrent or persistent disease · adults with growth‐hormone secreting pituitary adenomas
It is very uncertain whether surgery alone changes surgery for recurrent or persistent disease compared with preoperative pharmacological therapy and surgery (very low certainty).
1 finding from 1 review